subject: PUBCHEM.COMPOUND:5326857

subject_name: ZA


subject: PUBCHEM.COMPOUND:5326857

object_name: Osteosarcoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:5326857

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:5326857

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:5326857

object_name: Solid Neoplasm


subject: UMLS:C5706427

object_name: gastric adenocarcinoma


subject: UMLS:C5706427

object_name: pancreatic adenocarcinoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Miscarriage

tested_intervention: yes


subject: CHEBI:5801

object_name: spontaneous abortion


subject: RXCUI:605343

subject_name: Synera

object_name: osteoarthritis, knee


subject: UMLS:C0310090

subject_name: SALINE SOLUTION 0.9%

object_name: Childhood Breast Carcinoma


subject: UMLS:C0310090

object_name: breast carcinoma


subject: UMLS:C0310090

object_name: breast cancer


subject: UMLS:C0353697

subject_name: carbidopa / levodopa

object_name: cocaine dependence


subject: CHEBI:4798

subject_name: Entacapone


subject: PR:000007041

subject_name: very long chain fatty acid elongase 6


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Nasal Polyp


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Advanced cancer


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Inguinal hernia


subject: CHEBI:4717

subject_name: Droperidol


subject: CHEBI:4717

object_name: Post-Operative Pain


subject: CHEBI:60802

subject_name: ropivacaine


subject: HMDB:HMDB0033240

subject_name: Grevilline B

object_name: bladder tumor


subject: HMDB:HMDB0033240

object_name: urinary bladder carcinoma


subject: HMDB:HMDB0033240

object_name: urinary bladder cancer


subject: HMDB:HMDB0033240

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:41744

subject_name: Valrubicin


subject: PUBCHEM.COMPOUND:41744


subject: PUBCHEM.COMPOUND:41744


subject: PUBCHEM.COMPOUND:41744


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Sepsis


subject: PUBCHEM.COMPOUND:53477758

object_name: Sepsis, CTCAE


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: appendix cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:D056692

subject_name: Prebiotics

object_name: Diet, Healthy


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5779868

object_name: acute respiratory distress syndrome


subject: UMLS:C5779868

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5779868

object_name: pulmonary fibrosis


subject: UMLS:C5779868

object_name: Pulmonary Fibrosis, CTCAE


subject: UMLS:C5779868

object_name: Inflammation


subject: UMLS:C5779868

object_name: fibrosis


subject: UMLS:C5779868

object_name: respiratory system disorder


subject: UMLS:C5779868

object_name: lung disorder


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: primary progressive multiple sclerosis


subject: UNII:4F4X42SYQ6

object_name: secondary progressive multiple sclerosis


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: MESH:D055553

subject_name: Prescription Drugs

object_name: drug-induced liver injury


subject: UMLS:C0304227


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Adenocarcinoma endometrial recurrent


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Endometrioid Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Clear Cell Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Serous Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Mixed Cell Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Undifferentiated Carcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Endometrial Dedifferentiated Carcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial endometrioid adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: endometrium adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial clear cell adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial serous adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial mixed adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Endometrial Dedifferentiated Carcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial undifferentiated carcinoma


subject: UNII:DPT0O3T46P

object_name: undifferentiated carcinoma of the corpus uteri


subject: UNII:DPT0O3T46P

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UMLS:C2000809

object_name: Hypercholesterolemia


subject: CHEBI:32682

subject_name: L-argininium

object_name: Critical Illness


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C5854490

subject_name: Anti-TIM-3 Monoclonal Antibody BC3402

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5854490

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5854490

object_name: Myelodysplasia


subject: CHEBI:499361

subject_name: Aprepitant

object_name: endometrial cancer


subject: CHEBI:499361

object_name: uterine corpus cancer


subject: CHEBI:499361

object_name: endometrial carcinoma


subject: CHEBI:499361

object_name: cervical cancer


subject: CHEBI:499361

object_name: cervical carcinoma


subject: CHEBI:499361

object_name: fallopian tube carcinoma


subject: CHEBI:499361

object_name: fallopian tube cancer


subject: CHEBI:16796

subject_name: Melatonin

object_name: Obstructive sleep apnea of adult


subject: CHEBI:140422

subject_name: VR nerve agent

object_name: HIV infection


subject: CHEBI:73711

subject_name: Val-Arg


subject: CHEBI:157903

subject_name: Tyr-Cys

object_name: chronic obstructive pulmonary disease


subject: CHEBI:157903

object_name: acute respiratory distress syndrome


subject: CHEBI:157903

object_name: acute lung injury


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:33353


subject: UMLS:C0040642

subject_name: Transcobalamin


subject: UMLS:C0040642


subject: UMLS:C0040642


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: UNII:QE1Q24M65Y

subject_name: Aramchol


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Post-Operative Pain


subject: UMLS:C5203530

object_name: Contusions


subject: UMLS:C5203530

object_name: reported bruising (history)


subject: UMLS:C5203530

object_name: Bruising, CTCAE


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Upper Extremity Deep Vein Thrombosis, Secondary


subject: PUBCHEM.COMPOUND:22976653

object_name: CLABSI - central line associated bloodstream infection


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: CHEBI:15365

subject_name: Aspirin

object_name: skin melanoma


subject: CHEBI:91367

object_name: Solid Neoplasm


subject: UMLS:C1831923


subject: CHEBI:132922

object_name: Strain of neck muscle


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:3996

subject_name: Cyclobenzaprine


subject: UMLS:C5908012

subject_name: Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0733688

object_name: intermittent vascular claudication


subject: UMLS:C0733688

object_name: peripheral vascular disease


subject: UMLS:C0733688

object_name: arteriosclerosis disorder


subject: UMLS:C0733688

object_name: atherosclerosis


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Tumor Mass


subject: UMLS:C5907915

subject_name: Anti-PD-1 siRNA PH-762

object_name: skin squamous cell carcinoma


subject: UMLS:C5907915

object_name: Cutaneous Merkel Cell Carcinoma


subject: UMLS:C5907915


subject: CHEBI:474053

subject_name: Cefazolin

object_name: infection secondary to surgical procedure


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:57694

object_name: triple-negative breast carcinoma


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics


subject: CHEBI:48120

subject_name: anthracycline


subject: UMLS:C3896752

subject_name: Epothilone Analog UTD1


subject: UMLS:C3896752


subject: CHEBI:33364

subject_name: Platinum


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: PUBCHEM.COMPOUND:90467376

object_name: Depressive disorder in remission


subject: UMLS:C4053626

subject_name: LAG 525

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4053626

object_name: esophageal adenocarcinoma


subject: UMLS:C4053626

object_name: ovarian adenocarcinoma


subject: UMLS:C4053626

object_name: small cell lung carcinoma


subject: UMLS:C4053626

object_name: gastric adenocarcinoma


subject: UMLS:C4053626

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4053626

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4053626

object_name: sarcoma


subject: UMLS:C4053626

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4053626

object_name: soft tissue sarcoma


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C5445313

subject_name: Corn starch antigen

object_name: gastrointestinal toxicity


subject: UMLS:C5445313

object_name: female reproductive organ cancer


subject: DRUGBANK:DB11599

subject_name: Starch, corn


subject: DRUGBANK:DB11599


subject: UMLS:C5555764

subject_name: Ralzapastotug

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5555764


subject: UMLS:C5555764


subject: UMLS:C5555764

object_name: cervical cancer


subject: UMLS:C5555764

object_name: cervical carcinoma


subject: UMLS:C5555764

object_name: plasma cell myeloma


subject: UMLS:C5555764

object_name: carcinoma of esophagus


subject: UMLS:C5555764

object_name: esophageal cancer


subject: UMLS:C5555764

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5555764

object_name: neoplasm of esophagus


subject: UMLS:C5555764

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5555764

object_name: non-Hodgkin lymphoma


subject: UMLS:C5555764

object_name: Stomach cancer


subject: UMLS:C5555764

object_name: gastric cancer


subject: UMLS:C5555764

object_name: melanoma


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349

object_name: diffuse large B-cell lymphoma


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:3286

subject_name: Cabergoline

object_name: pituitary gland adenoma


subject: UMLS:C5418089

subject_name: Casdozokitug


subject: UMLS:C5418089

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5418089

object_name: clear cell renal carcinoma


subject: UMLS:C5418089

object_name: non-small cell lung carcinoma


subject: UMLS:C0163748

subject_name: Diosmectite

object_name: cancer


subject: UMLS:C0163748

object_name: neoplasm


subject: CHEBI:133354

subject_name: Bentonite


subject: CHEBI:133354


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:6532


subject: MESH:C000713810

subject_name: elderberry extract

object_name: influenza


subject: MESH:C000713810

object_name: Upper Respiratory Infections


subject: MESH:C000713810

object_name: Influenza-like illness


subject: MESH:C000713810


subject: MESH:C000713810

object_name: common cold


subject: MESH:C000713810

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:13444038

subject_name: Sugemalimab

object_name: extranodal nasal NK/T cell lymphoma


subject: PUBCHEM.COMPOUND:13444038

object_name: Lymphoma, Extranodal NK-T-Cell


subject: GTOPDB:12342

subject_name: sugemalimab


subject: GTOPDB:12342


subject: CHEMBL.COMPOUND:CHEMBL4594535

subject_name: SUGEMALIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594535


subject: UMLS:C4733610


subject: UMLS:C4733610


subject: PUBCHEM.COMPOUND:73059702

subject_name: Dutasteride + tamsulosin

object_name: lower urinary tract symptom


subject: UMLS:C2926870

subject_name: dutasteride / tamsulosin


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:95089

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: type 2 diabetes mellitus


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: cardiovascular disorder


subject: UNII:X587FW0372

object_name: Cardiovascular diseases in old age


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Relapse multiple myeloma


subject: CHEBI:68579

object_name: Plasma cell myeloma recurrent


subject: CHEBI:68579

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:68579

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:68579

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:68579

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:68579

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:68579

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:68579

object_name: Multiple myeloma progression


subject: CHEBI:68579

object_name: Multiple myeloma, without mention of having achieved remission


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: vaginal squamous cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: pancreatic neuroendocrine tumor


subject: UNII:52CMI0WC3Y

object_name: Neuroendocrine tumor of pancreas


subject: UNII:52CMI0WC3Y

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Peritoneal mesothelioma malignant recurrent


subject: UNII:52CMI0WC3Y

object_name: Recurrent Merkel Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Pleural mesothelioma malignant recurrent


subject: UNII:52CMI0WC3Y

object_name: Stage IVC Nasopharyngeal Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Nasopharyngeal cancer recurrent


subject: UNII:52CMI0WC3Y

object_name: neuroendocrine carcinoma


subject: UMLS:C3827082

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: UMLS:C3827082

object_name: vaginal squamous cell carcinoma


subject: UMLS:C3827082

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C3827082

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C3827082

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C3827082

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C3827082

object_name: Peritoneal mesothelioma malignant recurrent


subject: UMLS:C3827082

object_name: Recurrent Merkel Cell Carcinoma


subject: UMLS:C3827082

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3827082

object_name: Pleural mesothelioma malignant recurrent


subject: UMLS:C3827082

object_name: Stage IVC Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3827082

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3827082

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3827082

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3827082

object_name: Nasopharyngeal cancer recurrent


subject: UMLS:C3827082

object_name: neuroendocrine carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: vaginal squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: pancreatic neuroendocrine tumor


subject: UNII:2S9ZZM9Q9V

object_name: Neuroendocrine tumor of pancreas


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Peritoneal mesothelioma malignant recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Merkel Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Pleural mesothelioma malignant recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Nasopharyngeal Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: appendix adenocarcinoma


subject: MESH:C420448

subject_name: sebacoyl dinalbuphine ester

object_name: analgesia disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Childhood Oligoastrocytoma


subject: CHEBI:231614

object_name: oligoastrocytoma


subject: CHEBI:231614

object_name: ependymoma


subject: CHEBI:231614

object_name: childhood ependymoma


subject: CHEBI:231614

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:231614

object_name: Adult Ependymoma


subject: CHEBI:231614

object_name: Recurrent Malignant Glioma


subject: CHEBI:231614

object_name: anaplastic astrocytoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:49849451

subject_name: Anacetrapib

object_name: Hypercholesterolemia


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Delayed Graft Function


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: myositis


subject: PUBCHEM.COMPOUND:9831414

object_name: Muscle damage


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:15365

subject_name: Aspirin

object_name: asthma


subject: CHEBI:49662

subject_name: Indomethacin


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: rheumatoid arthritis


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: UNII:3T25U84H4U

subject_name: TELOTRISTAT ETIPRATE

object_name: ulcerative colitis


subject: UNII:3T25U84H4U

object_name: inflammatory bowel disease 1


subject: UMLS:C2825840

subject_name: Xermelo


subject: UMLS:C2825840


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: venous thromboembolism


subject: CHEBI:6888

object_name: thrombophilia due to thrombin defect


subject: CHEBI:6888

object_name: Graves disease


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Endometrial Intraepithelial Neoplasia


subject: CHEBI:231594

object_name: atypical endometrial hyperplasia


subject: CHEBI:231594

object_name: Overweight and obesity


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: CHEBI:36791

subject_name: Escitalopram

object_name: sleep apnea


subject: CHEBI:36791

object_name: Sleep Apnea, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Inguinal hernia


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Heartburn


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339

object_name: viral pneumonia


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: fragile X syndrome


subject: CHEBI:50693

subject_name: Milrinone

object_name: congenital diaphragmatic hernia


subject: CHEBI:50693

object_name: Hypoxemic Respiratory Failure


subject: CHEBI:50693

object_name: pulmonary hypoplasia


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: complicated appendicitis


subject: CHEBI:29007

object_name: Acute appendicitis NOS (disorder)


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: lichen planus, oral


subject: CHEBI:177298

object_name: prostate neoplasm


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Sickle Cell-SS Disease


subject: CHEBI:52717

object_name: Sickle Beta Plus Thalassemia


subject: CHEBI:52717

object_name: Sickle Beta 0 Thalassemia


subject: CHEBI:52717

object_name: sickle cell-beta-thalassemia disease syndrome


subject: CHEBI:52717

object_name: Cooley's anemia


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: sickle cell disease


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: chronic pain (diagnosis)


subject: UMLS:C2917659

object_name: Chronic pain


subject: DRUGBANK:DB19140

subject_name: Evexomostat

object_name: Carcinoma breast stage IV


subject: UMLS:C5666866


subject: UMLS:C5666866

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666866

object_name: Adult Solid Neoplasm


subject: UMLS:C5666866

object_name: Solid Neoplasm


subject: UMLS:C5666866

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:91976570

subject_name: Calcitonin gene-related peptide

object_name: migraine


subject: PUBCHEM.COMPOUND:91976570

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:JHB2QIZ69Z

subject_name: CALCITONIN GENE-RELATED PEPTIDE


subject: UNII:JHB2QIZ69Z


subject: CHEBI:9241

subject_name: Spironolactone

object_name: obstructive sleep apnea syndrome


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231679

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231679

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:135926

subject_name: Udenafil

object_name: Subcortical Vascular Dementia


subject: CHEBI:135926

object_name: vascular dementia


subject: UMLS:C2349009

subject_name: Zydena


subject: UMLS:C2349009


subject: UMLS:C4725090

subject_name: ALK/c-Met Inhibitor TQ-B3139


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: cocaine dependence


subject: DRUGBANK:DB17177

object_name: Childhood Brain Neoplasm


subject: DRUGBANK:DB17177

object_name: diffuse midline glioma, H3 K27M-mutant


subject: DRUGBANK:DB17177

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C0058409

subject_name: Dipinacoline glutamate


subject: UMLS:C0058409


subject: UMLS:C0058409


subject: CHEBI:36121

subject_name: flavylium

object_name: dental caries


subject: CHEBI:36121

object_name: Dental Caries, CTCAE


subject: CHEBI:4875

subject_name: Etanercept

object_name: vascular inflammations


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Obstruction


subject: CHEBI:74705

object_name: Anesthesia morbidity


subject: CHEBI:74705

object_name: Hypoventilation


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PUBCHEM.COMPOUND:167312358

subject_name: Bevonescein

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:167312358

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:167312358

object_name: Nerve injury


subject: PUBCHEM.COMPOUND:167312358

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:167312358

object_name: parotid gland neoplasm


subject: PUBCHEM.COMPOUND:167312358

object_name: Imaging problem


subject: UNII:5RG113V7K3

subject_name: BEVONESCEIN


subject: UNII:5RG113V7K3


subject: UNII:5RG113V7K3


subject: UNII:5RG113V7K3


subject: UNII:5RG113V7K3


subject: UNII:5RG113V7K3


subject: UMLS:C4053681

object_name: glioma


subject: UMLS:C4053681

object_name: malignant glioma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:87072389

subject_name: N'-hydroxy-N'-phenyloctanediamide

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:87072389

object_name: Alzheimer disease


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: UMLS:C2742459

object_name: Cognitive impairment


subject: UMLS:C2742459

object_name: schizophrenia


subject: DRUGBANK:DB16537

subject_name: Bacillus clausii

object_name: Acute gastroenteritis


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:C137DTR5RG

object_name: Pulmonary Complication


subject: UNII:C137DTR5RG

object_name: outcomes general quality of life


subject: UNII:C137DTR5RG

object_name: Perceived quality of life


subject: UNII:C137DTR5RG

object_name: Good quality of life


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Urinary incontinence


subject: CHEBI:135530

object_name: Urinary Incontinence, CTCAE 5.0


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Carcinoma of colon, stage I


subject: UNII:8M7YSN2KII

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: UNII:8M7YSN2KII

object_name: Stage I Colon Cancer AJCC v8


subject: UNII:8M7YSN2KII

object_name: Stage II Colon Cancer AJCC v8


subject: UNII:8M7YSN2KII

object_name: Stage II Colon Cancer AJCC v7


subject: UNII:8M7YSN2KII

object_name: Stage II Colon Cancer


subject: UNII:8M7YSN2KII

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:8M7YSN2KII

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:8M7YSN2KII

object_name: Stage III Colon Cancer


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:90227

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:90227

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:191502

subject_name: MS 3

object_name: leukemia


subject: CHEBI:191502

object_name: childhood leukemia


subject: CHEBI:2687

subject_name: Amsacrine


subject: CHEBI:2687


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: HIV infection


subject: GTOPDB:9098

subject_name: carotuximab

object_name: lung cancer


subject: GTOPDB:9098

object_name: lung neoplasm


subject: GTOPDB:9098

object_name: lung carcinoma


subject: GTOPDB:9098

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109321

subject_name: CAROTUXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: CHEBI:9150

subject_name: Simvastatin

object_name: intestinal neoplasm


subject: CHEBI:44915

subject_name: Propofol

object_name: cardiac arrest


subject: CHEBI:44915

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C3641626

subject_name: Targin

object_name: Low back pain


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Irritability


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:9168

subject_name: Sirolimus

object_name: congenital arteriovenous fistula


subject: CHEBI:9168

object_name: Arteriovenous fistula only (in use with two needles)


subject: CHEBI:9168

object_name: Complication of hemodialysis


subject: CHEBI:9168

object_name: Vascular Access Complication


subject: CHEBI:9168

object_name: Vascular Access Complication, CTCAE


subject: CHEBI:9168

object_name: Complication of renal dialysis


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: liver cirrhosis


subject: DRUGBANK:DB16369

subject_name: Matrix-M

object_name: severe acute respiratory syndrome


subject: CHEMBL.COMPOUND:CHEMBL4650407

subject_name: MATRIX-M1 ADJUVANT


subject: CHEBI:34618

subject_name: ceftibuten dihydrate

object_name: bacterial infectious disease


subject: CHEBI:3510

subject_name: Ceftibuten


subject: CHEBI:44915

object_name: endogenous depression


subject: CHEBI:44915

object_name: major depressive disorder


subject: GTOPDB:10752

subject_name: leronlimab

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109343

subject_name: LERONLIMAB


subject: UMLS:C3179325

subject_name: PRO 140


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Advanced cancer


subject: CHEBI:8382

subject_name: Prednisone

object_name: Pseudogout


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: male breast carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Breast Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: portal vein thrombosis


subject: CHEBI:68579

object_name: Portal Vein Thrombosis, CTCAE


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Schnitzler syndrome


subject: UMLS:C2718754

subject_name: Ilaris


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: Adherence To Medication Regime


subject: PUBCHEM.COMPOUND:72370618

object_name: Safety Issues


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:60481


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Pain Threshold


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: sickle cell disease


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: rectal carcinoma


subject: CHEBI:28787

object_name: rectal cancer


subject: CHEBI:28787

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: chronic kidney disease


subject: UMLS:C1527137

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C1527137

object_name: end stage renal failure


subject: UMLS:C1527137

object_name: Chronic uremia


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C1328728

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C1328728

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1328728

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C1328728

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C1328728

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C1328728

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1328728

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C1328728

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1328728

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1328728

object_name: MALT lymphoma


subject: UMLS:C1328728

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C1328728

object_name: splenic marginal zone lymphoma


subject: UMLS:C1328728

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C1328728

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C1328728

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C1328728

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C1328728

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C1328728

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C3827103

object_name: Small cell lung cancer extensive stage


subject: UNII:FA9BPX1T6V

subject_name: Epeleuton

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:75551

object_name: ovarian cancer


subject: CHEBI:75551

object_name: ovarian neoplasm


subject: CHEBI:75551

object_name: ovarian carcinoma


subject: CHEBI:75551

object_name: primary peritoneal carcinoma


subject: CHEBI:75551

object_name: Primary Peritoneal Cancer


subject: UMLS:C1527137

object_name: Sleep abnormality


subject: CHEBI:16796


subject: CHEBI:188074

object_name: hepatitis C


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:3535

subject_name: Cephalexin

object_name: cystic fibrosis


subject: CHEBI:3534


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C3896914


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: diabetic macular edema


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: CHEBI:58432

subject_name: histaminium

object_name: asthma


subject: CHEBI:58432

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:18295

subject_name: Histamine


subject: CHEBI:18295


subject: CHEBI:28666

subject_name: Leukotriene D4


subject: CHEBI:28666

object_name: Atopic rhinitis


subject: CHEBI:28666


subject: PUBCHEM.COMPOUND:3908


subject: PUBCHEM.COMPOUND:3908


subject: PUBCHEM.COMPOUND:3908


subject: CHEBI:63166

subject_name: leukotriene D4(1-)


subject: CHEBI:63166


subject: CHEBI:63166


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UNII:7D0YB67S97

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: UNII:7D0YB67S97

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:7D0YB67S97

object_name: Unclassified myelodysplastic syndrome


subject: UNII:7D0YB67S97

object_name: acute leukemia


subject: UNII:7D0YB67S97

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: UNII:7D0YB67S97

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: non-small cell lung carcinoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:31348

object_name: obesity


subject: CHEBI:31348

object_name: Obesity, CTCAE


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Embolism, Tumor


subject: CHEBI:231005

object_name: Neoplasm Metastasis


subject: CHEBI:231005

object_name: Metastasis


subject: CHEBI:231005

object_name: Metastatic Lesion


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:C88817F47Y

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:94295

subject_name: Darinaparsin

object_name: Advanced cancer


subject: CHEBI:110185

subject_name: Gnoscopine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:110185

object_name: non-Hodgkin lymphoma


subject: CHEBI:73237

subject_name: Noscapine


subject: CHEBI:73237


subject: CHEBI:47657

subject_name: Roflumilast

object_name: psoriasis


subject: PUBCHEM.COMPOUND:152165

object_name: cholecystitis


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:42797

subject_name: Gabapentin


subject: GTOPDB:8221

subject_name: epacadostat

object_name: melanoma


subject: GTOPDB:8221

object_name: glioblastoma


subject: GTOPDB:8221

object_name: Childhood Glioblastoma


subject: GTOPDB:8221

object_name: adult glioblastoma


subject: GTOPDB:8221

object_name: ovarian cancer


subject: GTOPDB:8221

object_name: ovarian neoplasm


subject: GTOPDB:8221

object_name: ovarian carcinoma


subject: GTOPDB:8221

object_name: adult lymphoma


subject: GTOPDB:8221

object_name: lymphoma


subject: GTOPDB:8221

object_name: pediatric lymphoma


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: PUBCHEM.COMPOUND:66577068

subject_name: CEVIMELINE HYDROCHLORIDE

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:66577068

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:66577068

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:66577068

object_name: Radiation Sickness


subject: PUBCHEM.COMPOUND:66577068

object_name: Oral Complication


subject: PUBCHEM.COMPOUND:83898

subject_name: cevimeline trans-sulfoxide


subject: PUBCHEM.COMPOUND:83898


subject: PUBCHEM.COMPOUND:83898


subject: PUBCHEM.COMPOUND:83898


subject: PUBCHEM.COMPOUND:83898


subject: PUBCHEM.COMPOUND:2684

subject_name: cevimeline


subject: PUBCHEM.COMPOUND:2684


subject: PUBCHEM.COMPOUND:2684


subject: PUBCHEM.COMPOUND:2684


subject: PUBCHEM.COMPOUND:2684


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: ureterolithiasis


subject: CHEBI:100241

object_name: Ureteral Calculi


subject: CHEBI:6801

subject_name: Metformin

object_name: malignant neoplasm of breast staging


subject: CHEBI:53493

subject_name: poly(D,L-lactic acid-co-glycolic acid)

object_name: cesarean section; infection


subject: UMLS:C0947694

subject_name: Vicryl


subject: CHEBI:51098

subject_name: Motesanib

object_name: breast neoplasm


subject: UMLS:C1541476

subject_name: AMG 706

object_name: Childhood Breast Carcinoma


subject: UMLS:C1541476

object_name: breast carcinoma


subject: UMLS:C1541476

object_name: breast cancer


subject: UMLS:C1541476


subject: UNII:696R5N4NRM

object_name: pulmonary hypertension, primary, 1


subject: UNII:696R5N4NRM

object_name: pulmonary hypertension


subject: UNII:696R5N4NRM

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:696R5N4NRM

object_name: pulmonary arterial hypertension


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:72317

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester

object_name: Acute Ischemic Stroke


subject: CHEBI:37537

object_name: Ischemic stroke


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule


subject: CHEBI:53394


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: CHEBI:61432


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: NK/T-cell lymphoma of nasal cavity


subject: UNII:7D96IR0PPM

object_name: Effects of chemotherapy


subject: UNII:7D96IR0PPM

object_name: Epigenetic disorder


subject: CHEBI:135918

subject_name: Tucidinostat


subject: CHEBI:135918


subject: CHEBI:135918


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Stomach cancer


subject: UMLS:C0016004

object_name: gastric cancer


subject: UMLS:C0016004

object_name: Anastomotic Leak


subject: PUBCHEM.COMPOUND:23663953

subject_name: Tianeptine sodium

object_name: treatment resistant depression


subject: PUBCHEM.COMPOUND:23663953


subject: UNII:YG0E19592I

subject_name: TIANEPTINE SODIUM


subject: UNII:YG0E19592I


subject: CHEBI:6456

subject_name: Lidocaine

object_name: heart failure


subject: CHEBI:6456

object_name: Heart Failure, CTCAE


subject: CHEBI:177298

object_name: endometrial carcinoma


subject: CHEBI:177298

object_name: ovarian serous adenocarcinoma


subject: CHEBI:177298

object_name: serous adenocarcinoma


subject: CHEBI:177298

object_name: serous cystadenocarcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: UMLS:C2697511

object_name: chronic hepatitis B virus infection


subject: UMLS:C2697511

object_name: hepatitis B


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: Adult Solid Neoplasm


subject: UNII:820NH671E6

object_name: Solid Neoplasm


subject: CHEBI:31355

subject_name: Carboplatin

object_name: KRAS Activating Mutation


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:135047

subject_name: Phenyltoloxamine

object_name: retinal vein occlusion


subject: PR:000010988

subject_name: cytosolic iron-sulfur assembly component 3


subject: UniProtKB:P14283

subject_name: PERT_BORPE Pertactin autotransporter (sprot)


subject: UNII:2BT4C47RUI

subject_name: Necitumumab

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:2BT4C47RUI

object_name: Malignant Solid Neoplasm


subject: CHEBI:109549

subject_name: Ramelteon

object_name: seasonal affective disorder


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: neurobehavioral manifestations


subject: UMLS:C4054273

object_name: endometrium neoplasm


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: aneurysm


subject: CHEBI:46195

object_name: peripheral vascular disease


subject: CHEBI:46195

object_name: heart disorder


subject: CHEBI:46195

object_name: stroke disorder


subject: CHEBI:46195

object_name: cerebrovascular disorder


subject: CHEBI:46195

object_name: transient ischemic attack


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UNII:D42O649ALL

subject_name: Telcagepant


subject: UNII:D42O649ALL


subject: UNII:D42O649ALL


subject: UNII:D42O649ALL


subject: UNII:D42O649ALL


subject: UNII:D42O649ALL


subject: UMLS:C3884615

object_name: Rheumatism


subject: UMLS:C3884615

object_name: inflammatory bowel disease


subject: UMLS:C2826382

object_name: cancer


subject: UMLS:C2826382

object_name: neoplasm


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: hepatitis C


subject: UMLS:C2346821

object_name: chronic hepatitis C virus infection


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: generalized anxiety disorder


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: retinal vein occlusion


subject: CHEBI:172923

object_name: macular degeneration


subject: CHEBI:172923

object_name: age-related macular degeneration


subject: CHEBI:172923

object_name: retinitis pigmentosa 30


subject: CHEBI:172923

object_name: diabetic retinopathy


subject: CHEBI:172923

object_name: retinal disease


subject: CHEBI:172923

object_name: Retinopathy


subject: CHEBI:172923

object_name: Retinopathy, CTCAE


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UMLS:C5237178


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: Inflammation


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:63607

subject_name: Linezolid

object_name: kidney failure


subject: CHEBI:63607

object_name: Renal Failure, CTCAE


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: UMLS:C5226856


subject: DRUGBANK:DB17848

object_name: Duchenne muscular dystrophy


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Androgen excess


subject: UNII:GY553LHC9E

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:GY553LHC9E

object_name: obesity


subject: UNII:GY553LHC9E

object_name: Obesity, CTCAE


subject: UMLS:C2703095

object_name: thyroid tumor


subject: UMLS:C2703095

object_name: thyroid gland carcinoma


subject: UMLS:C2703095

object_name: thyroid cancer


subject: UMLS:C2703095

object_name: Solid Neoplasm


subject: UMLS:C2703095

object_name: cholangiocarcinoma


subject: UMLS:C2703095

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C2703095

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C2703095

object_name: sarcoma


subject: UMLS:C2703095

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C2703095

object_name: soft tissue sarcoma


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:94770

subject_name: Pirarubicin

object_name: triple-negative breast carcinoma


subject: CHEBI:94770

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:4856

subject_name: Esmolol

object_name: subarachnoid hemorrhage


subject: UMLS:C4331925

subject_name: PANVAC

object_name: bladder tumor


subject: UMLS:C4331925

object_name: urinary bladder carcinoma


subject: UMLS:C4331925

object_name: urinary bladder cancer


subject: UMLS:C4331925

object_name: childhood bladder carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: endometrium neoplasm


subject: CHEBI:41879

object_name: uterine cancer


subject: CHEBI:41879

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:18220

subject_name: Isoflavone

object_name: Menopause present (finding)


subject: CHEBI:18220

object_name: Menopause


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: radiculopathy


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: hydronephrosis


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: allergic asthma


subject: HMDB:HMDB0013470

object_name: IgE-mediated allergic asthma


subject: HMDB:HMDB0013470

object_name: extrinsic asthma


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:52603


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: GTOPDB:5019


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEBI:16412


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: PR:000001155


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: pancreatic adenocarcinoma


subject: UMLS:C5204531

subject_name: A2AR/A2BR Antagonist AB928


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UMLS:C4521107


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: UMLS:C2826358


subject: UMLS:C4329323


subject: CHEMBL.COMPOUND:CHEMBL2109477

subject_name: SELICRELUMAB


subject: UMLS:C1869412


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Non-small cell lung cancer stage II


subject: CHEBI:73604

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: CHEBI:44177

subject_name: Isocyanomethane

object_name: Invasive meningococcal disease


subject: CHEBI:143712

subject_name: N. meningitidis group C polysaccharide


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Anterior Cruciate Ligament Tear


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:16796

subject_name: Melatonin

object_name: cerebral palsy


subject: CHEBI:16796

object_name: Growth & development aspects


subject: PUBCHEM.COMPOUND:72736758

subject_name: Simmiparib

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C000621690

subject_name: simmiparib


subject: CHEBI:8871

subject_name: Risperidone

object_name: Tourette syndrome


subject: CHEBI:204928

subject_name: Cefotaxime

object_name: Sepsis


subject: CHEBI:204928

object_name: Sepsis, CTCAE


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination


subject: UMLS:C0250480


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: pancreatic neoplasm


subject: UNII:TWF0ML1CK8

object_name: exocrine pancreatic carcinoma


subject: UNII:TWF0ML1CK8

object_name: malignant pancreatic neoplasm


subject: CHEBI:50733

subject_name: nutraceutical

object_name: long COVID-19


subject: CHEBI:91326

object_name: adult lymphoma


subject: CHEBI:91326

object_name: lymphoma


subject: CHEBI:91326

object_name: pediatric lymphoma


subject: CHEBI:91326

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:YLR364XYSA

object_name: Childhood Solid Neoplasm


subject: UNII:YLR364XYSA

object_name: Adult Solid Neoplasm


subject: UNII:YLR364XYSA

object_name: Solid Neoplasm


subject: UNII:YLR364XYSA

object_name: metastatic neoplasm


subject: UNII:YLR364XYSA

object_name: Embolism, Tumor


subject: UNII:YLR364XYSA

object_name: Neoplasm Metastasis


subject: UNII:YLR364XYSA

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:YLR364XYSA

object_name: Malignant Solid Neoplasm


subject: CHEBI:63610

subject_name: Misoprostol

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63610

object_name: obesity


subject: CHEBI:63610

object_name: Obesity, CTCAE


subject: CHEBI:63610

object_name: induced; birth


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: Pregnant


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Light chain (AL) amyloidosis


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: bladder tumor


subject: UMLS:C0301532

object_name: urinary bladder carcinoma


subject: UMLS:C0301532

object_name: urinary bladder cancer


subject: UMLS:C0301532

object_name: childhood bladder carcinoma


subject: CHEBI:77590

subject_name: Armodafinil

object_name: Fibromyalgia, Primary


subject: CHEBI:31859

subject_name: Modafinil


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101

object_name: metastatic melanoma


subject: UMLS:C2348637

object_name: head and neck cancer


subject: CHEBI:77260

subject_name: Omeprazole

object_name: venous thromboembolism


subject: CHEBI:77260

object_name: thrombophilia due to thrombin defect


subject: CHEBI:77260

object_name: Blood Clot


subject: CHEBI:77260

object_name: thrombosis


subject: CHEBI:77260

object_name: Thrombus


subject: CHEBI:77260

object_name: Gastrointestinal hemorrhage


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Weight loss


subject: CHEBI:65353

object_name: Weight Loss, CTCAE


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: autoimmune hepatitis


subject: CHEBI:72296

subject_name: Apixaban

object_name: Acute Ischemic Stroke


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Cough


subject: CHEBI:94559

object_name: Cough, CTCAE


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Nutritional Rickets


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: rickets


subject: MESH:D002136


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2


subject: PUBCHEM.COMPOUND:3249


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:57694

object_name: cardiovascular disorder


subject: CHEBI:57694

object_name: Overweight and obesity


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:50733


subject: CHEBI:32599

object_name: asthma


subject: UMLS:C1260201

subject_name: AMG 073

object_name: Renal rickets


subject: CHEBI:48390

subject_name: Cinacalcet


subject: PR:000044407

subject_name: homoserine dehydrogenase

object_name: rheumatoid arthritis


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: chronic obstructive pulmonary disease


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: hypotension


subject: MESH:D000077325

object_name: Hypotension, CTCAE


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Non-small cell lung cancer stage III


subject: UNII:IZT740JY57

object_name: colorectal cancer


subject: UNII:IZT740JY57

object_name: colorectal carcinoma


subject: UNII:IZT740JY57

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Microsatellite instability-high colorectal cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: PUBCHEM.COMPOUND:85867

object_name: Surgical Wound Infection


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: sickle cell disease


subject: CHEBI:68579

object_name: Sickle cell-beta^0^-thalassemia


subject: CHEBI:8502

subject_name: Propylthiouracil

object_name: Safety Issues


subject: CHEBI:8502

object_name: Drug Interactions


subject: CHEBI:76018

subject_name: Riociguat


subject: CHEBI:76018


subject: CHEBI:8028

subject_name: Perphenazine


subject: CHEBI:8028


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib

object_name: Immunoglobulin G4-Related Disease


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Ewing Sarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632

object_name: Refractory Osteosarcoma


subject: CHEBI:63632

object_name: Osteosarcoma recurrent


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: cauda equina syndrome with neurogenic bladder


subject: PUBCHEM.COMPOUND:9891967

object_name: Neurogenic bladder


subject: PUBCHEM.COMPOUND:9891967

object_name: Dysfunctional voiding of urine


subject: CHEBI:4474

subject_name: Dezocine

object_name: Acne atrophica


subject: CHEBI:91402

subject_name: linsitinib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:91402

object_name: Prostate cancer recurrent


subject: CHEBI:91402

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:91402

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:91402

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:91402

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:91402

object_name: prostate adenocarcinoma


subject: UNII:15A52GPT8T

subject_name: Linsitinib


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: sleep disorder


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:18220

subject_name: Isoflavone

object_name: Childhood Breast Carcinoma


subject: CHEBI:18220

object_name: breast carcinoma


subject: CHEBI:18220

object_name: breast cancer


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: Post-Operative Pain


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: UNII:2M3055079H

subject_name: Brivudine

object_name: herpes zoster


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Overweight and obesity


subject: CHEBI:60802

subject_name: ropivacaine


subject: UMLS:C0445115

subject_name: Normal saline

object_name: acute respiratory distress syndrome


subject: UMLS:C0445115

object_name: adult acute respiratory distress syndrome


subject: UMLS:C1382107

subject_name: Suspension substance


subject: UMLS:C1382107


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:DPT0O3T46P


subject: CHEBI:94366

subject_name: itraconazole

object_name: sporotrichosis


subject: UNII:N7T15V1FUY

subject_name: Setmelanotide

object_name: Bardet-Biedl syndrome


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: Blood Pressure Finding


subject: CHEBI:189965

object_name: Systemic arterial pressure


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: UMLS:C4086318

subject_name: Fluorine F 18 FP-R01-MG-F2

object_name: sclerosing cholangitis


subject: UMLS:C4086318

object_name: primary sclerosing cholangitis


subject: UMLS:C4086318

object_name: interstitial lung disease 1


subject: UMLS:C4086318

object_name: interstitial lung disease 2


subject: UMLS:C4086318

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C5237361

subject_name: Immediate-release Bupropion

object_name: metastatic melanoma


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UMLS:C3257521

subject_name: coconut extract

object_name: Body Composition


subject: DRUGBANK:DB10523

subject_name: Coconut


subject: CHEBI:59877

subject_name: Enalaprilat

object_name: type 2 diabetes mellitus


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4786


subject: UMLS:C0014027

subject_name: enalaprilat


subject: PUBCHEM.COMPOUND:24868177

subject_name: neuropeptide Y


subject: CHEBI:80201

subject_name: Neuropeptide Y


subject: PR:000011387


subject: CHEBI:91872

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:91872

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:91872

object_name: Advanced Adult Hepatocellular Carcinoma


subject: CHEBI:91872

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:91872

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:147398

subject_name: Tideglusib

object_name: progressive supranuclear palsy


subject: CHEBI:77572

subject_name: Tranilast

object_name: Hyperuricemia


subject: CHEBI:77572

object_name: Hyperuricemia, CTCAE


subject: CHEBI:77572

object_name: gout


subject: CHEBI:134689

subject_name: Rucaparib

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:134689

object_name: clear cell adenocarcinoma


subject: CHEBI:134689

object_name: primary peritoneal carcinoma


subject: CHEBI:134689

object_name: Primary Peritoneal Cancer


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: diabetes mellitus


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: childhood kidney cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297724

subject_name: CERTOPARIN

object_name: Thromboembolism


subject: UMLS:C0592534

subject_name: certoparin sodium


subject: UMLS:C0592532

subject_name: certoparin


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: Stage I Bladder Cancer AJCC v8


subject: UMLS:C0678021

object_name: Stage I Carcinoma of Bladder


subject: UMLS:C0678021

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C0678021

object_name: Stage IV Bladder Cancer AJCC v7


subject: UMLS:C0678021

object_name: Bladder cancer stage IV


subject: UMLS:C0678021

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C0678021

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: UMLS:C0678021

object_name: Stage II Bladder Cancer AJCC v8


subject: UMLS:C0678021

object_name: Bladder cancer recurrent


subject: UMLS:C0678021

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UMLS:C0678021

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C0678021

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:11822705

subject_name: Bcl-2 Inhibitor

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:11822705

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:11822705

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:11822705

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C4319834

subject_name: B-cell lymphoma 2 inhibitor


subject: UMLS:C4319834


subject: UMLS:C4319834


subject: UMLS:C4319834


subject: UMLS:C4256990

subject_name: BCL-2 Inhibitor [EPC]


subject: UMLS:C4256990


subject: UMLS:C4256990


subject: UMLS:C4256990


subject: CHEBI:24261

subject_name: glucocorticoid


subject: CHEBI:24261


subject: CHEBI:24261


subject: CHEBI:24261


subject: CHEBI:30884

subject_name: glycoloyl group


subject: CHEBI:30884


subject: CHEBI:30884


subject: CHEBI:30884


subject: CHEBI:73890

subject_name: Gly-Cys


subject: CHEBI:73890


subject: CHEBI:73890


subject: CHEBI:73890


subject: CHEBI:91512


subject: CHEBI:91512


subject: CHEBI:91512


subject: CHEBI:91512


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: CHEBI:71019


subject: CHEBI:71019


subject: CHEMBL.COMPOUND:CHEMBL4297706

object_name: Childhood Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297706

object_name: Malignant Solid Neoplasm


subject: UMLS:C4329317

subject_name: Anti-CD73 Monoclonal Antibody BMS-986179


subject: UMLS:C4329317


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: PUBCHEM.COMPOUND:156195543

subject_name: REZATAPOPT

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:156195543

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:156195543

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:156195543

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:156195543

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:156195543

object_name: acute myeloid leukemia


subject: DRUGBANK:DB18980

subject_name: Rezatapopt


subject: DRUGBANK:DB18980


subject: DRUGBANK:DB18980


subject: DRUGBANK:DB18980


subject: DRUGBANK:DB18980


subject: DRUGBANK:DB18980


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: ventricular tachycardia


subject: UNII:UC95NQ339C

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: UNII:UC95NQ339C

object_name: continuous electrocardiogram ventricular tachycardia


subject: UNII:UC95NQ339C

object_name: Ventricular Tachycardia by ECG Finding


subject: UNII:UC95NQ339C

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UNII:33639WNC7Q

object_name: cancer


subject: UMLS:C3852556


subject: UMLS:C3658787

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3658787

object_name: Hodgkin Disease


subject: UMLS:C3658787

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C3658787

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C3658787

object_name: acute lymphoblastic leukemia


subject: UMLS:C3658787

object_name: plasma cell myeloma


subject: UMLS:C3658787

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3658787

object_name: rectum adenocarcinoma


subject: UMLS:C3658787

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3658787

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3658787

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3658787

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C3658787

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C3658787

object_name: sarcoma


subject: UMLS:C3658787

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C3658787

object_name: soft tissue sarcoma


subject: UMLS:C3658787

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C3658787

object_name: rhabdomyosarcoma


subject: UMLS:C3658787

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C3658787

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C3658787

object_name: Ewing sarcoma


subject: UMLS:C2718086

subject_name: PSD 502

object_name: premature ejaculation


subject: UMLS:C4548529

subject_name: DTaP-IPV-HB-PRP-T vaccine

object_name: tetanus


subject: UMLS:C3537001

subject_name: ALT 711

object_name: Heart Failure, CTCAE


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: hepatitis C


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: neuralgia


subject: CHEBI:6339

object_name: Neuralgia, CTCAE


subject: CHEBI:6339

object_name: herpes zoster


subject: CHEBI:6339

object_name: postherpetic neuralgia


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Migrainous vertigo


subject: UMLS:C4287724

object_name: Geographic atrophy


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: preterm premature rupture of the membranes


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: CHEBI:95021

subject_name: pemetrexed

object_name: neoplasm of esophagus


subject: CHEBI:63724


subject: CHEBI:42588

subject_name: Fenretinide

object_name: acute myeloid leukemia


subject: CHEBI:42588

object_name: acute lymphoblastic leukemia


subject: CHEBI:42588

object_name: non-Hodgkin lymphoma


subject: UMLS:C5556659

subject_name: Anti-EGFRvIII/CD3 Bispecific Antibody hEGFRvIII:CD3 bi-scFv

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C5556659

object_name: Recurrent Glioblastoma


subject: UMLS:C4282062

subject_name: Cynara scolymus whole extract

object_name: type 2 diabetes mellitus


subject: UMLS:C1446447

subject_name: Cynara scolymus antigen


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: metastatic colorectal cancer


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib


subject: UMLS:C5565994


subject: CHEBI:9927

subject_name: Valsartan

object_name: acute respiratory distress syndrome


subject: CHEBI:9927

object_name: adult acute respiratory distress syndrome


subject: CHEBI:9927


subject: CHEBI:9927

object_name: severe acute respiratory syndrome


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin

object_name: alopecia areata


subject: PUBCHEM.COMPOUND:9832423

object_name: alopecia


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: RXCUI:476348


subject: CHEBI:31348

subject_name: Capecitabine

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:31348

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Neoplasm of uncertain or unknown behavior of breast


subject: UNII:2S9ZZM9Q9V

object_name: Breast problem


subject: UNII:2S9ZZM9Q9V

object_name: small cell carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: Mantle cell lymphoma refractory


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: mantle cell lymphoma


subject: UMLS:C2348229

subject_name: NovaSoy

object_name: Depressed mood


subject: UMLS:C2348229

object_name: Cancer patients and suicide and depression


subject: UMLS:C2348229

object_name: Depressed - symptom


subject: UMLS:C2348229

object_name: Depression, CTCAE


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:90227

object_name: Embolism, Tumor


subject: CHEBI:90227

object_name: Neoplasm Metastasis


subject: UMLS:C3489751

object_name: neuralgia


subject: UNII:14FDK6ISC9

object_name: Adult Solid Neoplasm


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Blister at injection site


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Transplant-Related Carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C5556674

subject_name: pH Low Insertion Peptide-exatecan Conjugate CBX-12


subject: UMLS:C5556674

object_name: ovarian carcinoma


subject: UMLS:C5556674

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5556674

object_name: non-small cell lung carcinoma


subject: UMLS:C5556674

object_name: small cell lung carcinoma


subject: UMLS:C5556674

object_name: urothelial carcinoma


subject: UMLS:C5556674

object_name: transitional cell carcinoma


subject: UMLS:C5556674

object_name: colorectal cancer


subject: UMLS:C5556674

object_name: colorectal carcinoma


subject: UMLS:C5556674

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5556674

object_name: esophageal cancer


subject: UMLS:C5556674

object_name: appendix cancer


subject: UMLS:C5556674

object_name: appendix carcinoma


subject: UMLS:C5556674

object_name: pancreatic neoplasm


subject: UMLS:C5556674

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5556674

object_name: malignant pancreatic neoplasm


subject: UMLS:C5556674

object_name: Stomach cancer


subject: UMLS:C5556674

object_name: gastric cancer


subject: UMLS:C5556674

object_name: Childhood Breast Carcinoma


subject: UMLS:C5556674

object_name: breast carcinoma


subject: UMLS:C5556674

object_name: breast cancer


subject: UMLS:C5556674

object_name: malignant soft tissue neoplasm


subject: UMLS:C5556674

object_name: sarcoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C3249258

subject_name: Gadolinium-based Contrast Agent [EPC]

object_name: Alzheimer disease type 1


subject: UMLS:C3249258

object_name: Alzheimer disease


subject: UMLS:C5203141

subject_name: Gadolinium-based Contrast Agent


subject: UMLS:C5203141


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Primary malignant neoplasm


subject: UNII:3XPI7EG4W8

object_name: cancer


subject: UNII:3XPI7EG4W8

object_name: childhood malignant neoplasm


subject: UNII:3XPI7EG4W8

object_name: Malignant obstetric neoplasm


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: CHEBI:63791

object_name: EBV Infection


subject: UMLS:C0376565

subject_name: Anti-HIV Agents

object_name: HIV infection


subject: UMLS:C0982054

subject_name: Candida antigen

object_name: common wart


subject: MESH:C038435

object_name: Plasmodium falciparum malaria


subject: UMLS:C5239612

subject_name: Tact


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: Crohn disease


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: Inflammation


subject: UMLS:C5853357


subject: UMLS:C5853357


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: ulcerative colitis


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Surgical procedure finding


subject: CHEBI:135935

subject_name: Tapentadol

object_name: Post-Operative Pain


subject: CHEBI:135935

object_name: Acute Pain


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:10206564

subject_name: alpha-Tocopheryloxyacetic acid

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:10206564

object_name: Refractory Breast Carcinoma


subject: PUBCHEM.COMPOUND:10206564

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10206564

object_name: HER2 positive breast carcinoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: UMLS:C0338204

subject_name: Herceptin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Nausea and vomiting


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:41879

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:41879

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:41879

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:41879

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:41879

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:41879

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:41879

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:41879

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:41879

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:41879

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:41879

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:41879

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:41879

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:64321

subject_name: Fosaprepitant


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: CHEBI:9584

subject_name: desiccated thyroid extract

object_name: Primary hypothyroidism


subject: UMLS:C0040134

subject_name: thyroid (USP)


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UNII:C8Q2RMU41O

subject_name: BAMOSIRAN

object_name: OPTN-related open angle glaucoma


subject: UNII:C8Q2RMU41O

object_name: open-angle glaucoma


subject: UNII:C8Q2RMU41O

object_name: ocular hypertension


subject: UNII:C8Q2RMU41O

object_name: Ocular hypertension


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Abdominal Infection


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: childhood acute myeloid leukemia


subject: UMLS:C0591457

subject_name: Erwinase


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: autosomal dominant hypocalcemia


subject: MESH:D002136

object_name: Hypocalcemia


subject: MESH:D002136

object_name: Serum calcium below normal (finding)


subject: MESH:D002136

object_name: Hypocalcemia, CTCAE


subject: MESH:D002136

object_name: bone Paget disease


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat

object_name: Cushing Disease


subject: MESH:C000716647


subject: CHEBI:91529

object_name: myofascial pain syndrome


subject: PUBCHEM.COMPOUND:287691

subject_name: Thiocolchicoside


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: malaria


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Parkinson disease


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:31623

subject_name: Fluocinolone acetonide

object_name: Neoplasm Metastasis


subject: CHEBI:31623

object_name: breast neoplasm


subject: PR:000022660

subject_name: flagellum-specific ATP synthase


subject: PR:000022660


subject: UniProtKB:P52612

subject_name: FLII_ECOLI Flagellum-specific ATP synthase (sprot)


subject: UniProtKB:P52612


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Chronic neuropathic pain


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: female infertility


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C3854053

subject_name: Rhodiola extract

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3854053


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Malignant neoplasm of stomach stage II


subject: UNII:JJX4JHS4PO

object_name: pancreatic neoplasm


subject: UNII:JJX4JHS4PO

object_name: exocrine pancreatic carcinoma


subject: UNII:JJX4JHS4PO

object_name: malignant pancreatic neoplasm


subject: UMLS:C2346687


subject: UMLS:C2346687


subject: UMLS:C2346687


subject: CHEBI:15379

subject_name: Oxygen

object_name: diabetic kidney disease


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: cannabis abuse


subject: CHEBI:109549

subject_name: Ramelteon


subject: CHEBI:10125

subject_name: Zolpidem


subject: UMLS:C1831991

subject_name: Carcinoembryonic Antigen-Expressing Measles Virus

object_name: ovarian cancer


subject: UMLS:C1831991

object_name: ovarian neoplasm


subject: UMLS:C1831991

object_name: ovarian carcinoma


subject: UMLS:C1831991

object_name: peritoneum cancer


subject: UMLS:C4744993

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: DRUGBANK:DB16750

object_name: digestive system disorder


subject: DRUGBANK:DB16750

object_name: digestive system neoplasm


subject: DRUGBANK:DB16750

object_name: Neoplasm of the gastrointestinal tract


subject: DRUGBANK:DB16750

object_name: connective and soft tissue neoplasm


subject: DRUGBANK:DB16750

object_name: connective tissue neoplasm


subject: DRUGBANK:DB16750

object_name: Neoplasms by Histologic Type


subject: DRUGBANK:DB16750

object_name: neoplasm


subject: CHEBI:231679

subject_name: ipilimumab

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:231679

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:231679

object_name: testicular lymphoma


subject: CHEBI:231679

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:231679

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:231679

object_name: refractory hairy cell leukemia


subject: CHEBI:231679

object_name: intraocular lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:231679

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:231679

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:231679

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:231679

object_name: small intestine lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:231679

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:231679

object_name: splenic marginal zone lymphoma


subject: CHEBI:231679

object_name: MALT lymphoma


subject: CHEBI:231679

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:231679

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:231679

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Female sexual dysfunction


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Bowel incontinence


subject: CHEBI:71940

object_name: Fecal Incontinence, CTCAE


subject: CHEBI:71940

object_name: Stress urinary incontinence


subject: UNII:1W14T9L25W

subject_name: navicixizumab

object_name: ovarian cancer


subject: UNII:1W14T9L25W

object_name: ovarian neoplasm


subject: UNII:1W14T9L25W

object_name: ovarian carcinoma


subject: UNII:1W14T9L25W

object_name: fallopian tube carcinoma


subject: UNII:1W14T9L25W

object_name: fallopian tube cancer


subject: UNII:1W14T9L25W

object_name: primary peritoneal carcinoma


subject: UNII:1W14T9L25W

object_name: papillary serous cystadenocarcinoma


subject: UNII:1W14T9L25W

object_name: peritoneal carcinoma


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: alcohol abuse


subject: UMLS:C1250042

object_name: alcohol dependence


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: membranous glomerulonephritis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Tractional retinal detachment


subject: CHEBI:127342

subject_name: Atomoxetine


subject: CHEBI:127342


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: food allergy


subject: UMLS:C3658854


subject: CHEBI:24757

subject_name: Hypochlorite

object_name: Neonatal infection


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: hepatobiliary disorder


subject: UNII:3A189DH42V

object_name: liver disorder


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Tuberous sclerosis complex associated neuropsychiatric disease


subject: UMLS:C1831753

subject_name: pNGVL3-hICD Vaccine

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1831753

object_name: Carcinoma breast stage IV


subject: UMLS:C1831753

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: HER2 positive breast carcinoma


subject: UMLS:C1831753

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C1831753

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C1831753

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1831753

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1831753

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1831753

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1831753

object_name: Ovarian cancer stage III


subject: UMLS:C1831753

object_name: Ovarian germ cell cancer stage IV